Michael Hanley

CNS pipeline · person

Michael Hanley, MBA

Chief Operating Officer of Alto Neuroscience since May 2024, with over 25 years of life-sciences leadership focused on CNS disorders. Previously Chief Commercial and Chief Business Officer at Aeglea BioTherapeutics, General Manager at Horizon Therapeutics, and Head of US Sales for Lundbeck's psychiatry division.

  • 1 company

Courtesy Alto Neuroscience

Current roles

Appears with

People sharing a company with Michael.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.